Abstract:Fungi are ubiquitous. Yet, despite our frequent exposure to commensal fungi of the normal mammalian microbiota and environmental fungi, serious, systemic fungal infections are rare in the general population. Few, if any, fungi are obligate pathogens that rely on infection of mammalian hosts to complete their lifecycle; however, many fungal species are able to cause disease under select conditions. The distinction between fungal saprophyte, commensal, and pathogen is artificial and heavily determined by the ability of an individual host's immune system to limit infection. Dramatic examples of commensal fungi acting as opportunistic pathogens are seen in hosts that are immune compromised due to congenital or acquired immune deficiency. Genetic variants that lead to immunological susceptibility to fungi have long been sought and recognized. Decreased myeloperoxidase activity in neutrophils was first reported as a mechanism for susceptibility to <i>Candida</i> infection in 1969. The ability to detect genetic variants and mutations that lead to rare or subtle susceptibilities has improved with techniques such as single nucleotide polymorphism (SNP) microarrays, whole exome sequencing (WES), and whole genome sequencing (WGS). Still, these approaches have been limited by logistical considerations and cost, and they have been applied primarily to Mendelian impairments in anti-fungal responses. For example, loss-of-function mutations in <i>CARD9</i> were discovered by studying an extended family with a history of fungal infection. While discovery of such mutations furthers the understanding of human antifungal immunity, major Mendelian susceptibility loci are unlikely to explain genetic disparities in the rate or severity of fungal infection on the population level. Recent work using unbiased techniques has revealed, for example, polygenic mechanisms contributing to candidiasis. Understanding the genetic underpinnings of susceptibility to fungal infections will be a powerful tool in the age of personalized medicine. Future application of this knowledge may enable targeted health interventions for susceptible individuals, and guide clinical decision making based on a patient's individual susceptibility profile.

Innate immune signal transduction pathways to fungal infection: Components and regulation

Innate Immune Cell Response Upon Candida Albicans Infection

Innate Immune Cell Response Upon Candida albicans Infection.

[Progress on the Role of Toll-like Receptors in Candida Albicans Infections].

Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies

A Human Commensal-Pathogenic Fungus Suppresses Host Immunity Via Targeting TBK1

Mechanisms and Pathways of Innate Immune Activation and Regulation in Health and Cancer.

The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida

Monocytes and the Host Response to Fungal Pathogens

Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi

Components of the Calcium-Calcineurin Signaling Pathway in Fungal Cells and Their Potential As Antifungal Targets

Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

The advances in the regulation of immune microenvironment by Candida albicans and macrophage cross-talk

Antifungal Innate Immunity: A Perspective from the Last 10 Years

Innate immune responses against the fungal pathogen Candida auris

The effect of herbal medicine in innate immunity to Candida albicans

Innate Immunity against Cryptococcus, from Recognition to Elimination

Promising immunotherapeutic targets for treating candidiasis

Immune Interactions with Pathogenic and Commensal Fungi

Role of Toll-like receptors in systemic Candida albicans infections

Dermatophyte infection: from fungal pathogenicity to host immune responses